U.S. market Open. Closes in 1 hour 6 minutes

CYAD | Celyad Oncology SA Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
RevenueN/AN/A5.00K6.00K3.12M3.54M8.52M3.00K146.00KN/A54.00K26.93K
Cost of RevenueN/AN/AN/AN/AN/A515.00K53.00K1.00K115.00K2.42M6.68M5.80M
Gross ProfitN/AN/A5.00K6.00K3.12M3.02M8.47M2.00K31.00K-2.42M-6.63M-5.77M
Operating Expenses20.26M26.91M26.24M29.38M34.50M29.82M34.72M29.77M19.92M11.08M-5.19M3.31M
Selling, General & Admin10.34M9.66M8.99M8.72M10.80M9.84M10.30M8.12M5.41M3.19M3.71M2.84M
Research & Development18.93M20.77M21.59M25.23M24.95M22.91M27.68M22.77M15.87M2.16MN/AN/A
Other Operating Expenses-9.00M-3.53M-4.34M-4.58M-1.24M-2.93M-3.25M-1.11M-1.36M5.73M-8.90M472.93K
Operating Income-40.86M-26.39M-26.24M-29.37M-38.17M-52.88M-25.61M-29.77M-19.89M-11.08M-1.44M-9.08M
Other Expenses / Income-13.00K-111.00K9.04M733.00K743.00K-3.52M2.00M658.00K3.43M-1.27M-711.63K-51.81K
Before Tax Income-40.87M-26.50M-17.20M-28.64M-37.43M-56.40M-23.61M-29.11M-16.45M-12.35M-2.15M-9.13M
Income Tax Expenses65.00K10.00K297.00K-8.00K805.00K-1.00K-6.00KN/AN/AN/AN/AN/A
Net Income-40.94M-26.51M-17.50M-28.63M-37.43M-56.40M-23.61M-29.11M-16.45M-12.35M-2.15M-9.13M
Interest Expenses197.00K255.00K297.00K343.00K62.00K108.00K109.00K100.00K22.00K425.42KN/AN/A
Basic Shares Outstanding22.59M15.60M13.94M12.52M11.14M9.62M9.33M8.49M6.75M4.10M6.33M6.33M
Diluted Shares Outstanding22.59M15.60M13.94M12.52M11.14M9.62M9.33M8.49M6.75M4.10M6.33M6.33M
EBITDA-18.81M-25.58M-24.19M-27.45M-36.25M-47.28M-21.99M-27.98M-15.56M-11.04M-1.26M-6.41M
EBITDA Margin0.00%0.00%-483,840.00%-457,500.00%-1,163.76%-1,335.71%-257.97%-932,700.00%-10,658.22%0.00%-2,330.99%-23,813.98%
EBIT-40.67M-26.25M-16.91M-28.30M-36.56M-56.29M-23.50M-29.01M-16.43M-11.92M-2.15M-9.13M
EBIT Margin0.00%0.00%-338,140.00%-471,616.67%-1,173.68%-1,590.06%-275.76%-967,133.33%-11,254.11%0.00%-3,986.20%-33,916.42%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙